KCT0002066已完成未知
Single-arm, single-blind, two center, 24 week design clinical study to evaluate the safety and efficacy of Lipen-D for glans penis augmentation
Chunghwa Medipower0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 o Limit（—）
- 性别
- Male
入选标准
- •healthy men, aged 20 or over
- •- men with small penis syndrome
- •- during the study period, subject will not received any treatments associated with penile augmentation
- •- subject will agree with investigator's decision
- •- subject will sign an informed consent form
排除标准
- •- any history of psychological or psychiatric illness,
- •- congenital or acquired penile malformation including severe phimosis,
- •- previous penile augmentation history,
- •- any chronic major systemic disease including diabetes and coagulopathy
研究者
相似试验
招募中
不适用
A 12-week, Single-centre, Randomized, Double-blind, Placebo Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of HUN2-434 on Improving Muscle StrengthKCT0009310Dong-A University Hospital100
进行中（未招募）
不适用
ot applicable.type 2 diabetes mellitusMedDRA version: 14.1Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2009-017061-28-PLAstraZeneca AB940
进行中（未招募）
不适用
ot applicable.type 2 diabetes mellitusMedDRA version: 15.1Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentSystem Organ Class: 100000004861EUCTR2009-017061-28-DEAstraZeneca AB940
进行中（未招募）
不适用
ot applicableEUCTR2009-016791-71-DEAstraZeneca AB1,175
进行中（未招募）
1 期
ot applicabletype 2 diabetes mellitusMedDRA version: 14.0Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2009-016791-71-SKAstraZeneca AB1,175